Abstract
A number of recent studies have investigated the expression of topoisomerase II in clinical leukemia specimens. Here we outline the rationale for these studies, identify potential pitfalls, summarize recent results, and discuss unanswered questions in this area.
Original language | English (US) |
---|---|
Pages (from-to) | 217-237 |
Number of pages | 21 |
Journal | Leukemia and Lymphoma |
Volume | 29 |
Issue number | 3-4 |
DOIs | |
State | Published - Jan 1 1998 |
Keywords
- Antileukemic therapy
- Response to therapy
- Topoisomerase II
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research